Religiously Integrated Cognitive Behavioral Therapy

December 31, 2025 updated by: Dilek Ekinci, Ibn Haldun University

Religiously Integrated Cognitive Behavioral Group Therapy for Generalized Anxiety Disorder

This study aims to examine the effect of a newly developed religously oriented cognitive behavioral group therapy program on the level of anxiety and well-being in young adults compared to the traditional cognitive behavioral therapy-based program.

Hypoteses 1 Religiously oriented CBT group therapy will be more effective in reducing participants' general anxiety levels compared to traditional CBT group therapy and the control group, and this effect will continue in the two-month follow-up measurements.

Hypoteses 2 Religiously oriented CBT group therapy will be more effective in increasing participants' levels of well-being compared to traditional CBT group therapy and the control group, and this effect will continue in the two-month follow-up measurements.

Study Overview

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Being between 18 and 45 years of age, Willingness to participate in 10 weekly group sessions, Having a GAD-7 score of 5 or higher, Exhibiting symptoms of generalized anxiety disorder as determined by the Structured Clinical Interview for DSM-5 (SCID-5-CV), Having regular access to the internet.

Exclusion Criteria:

Currently receiving any form of psychological treatment Having previously undergone long-term psychotherapy Having a primary comorbid psychological disorder other than generalized anxiety disorder, Expressing suicidal ideation, Having completed only primary school education

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional Cognitive Behavioral Group Therapy
Participants in this group received 10 sessions of online cognitive behavioral group therapy
his intervention consists of a structured, group-based, online cognitive behavioral therapy program focusing on anxiety management. The program includes psychoeducation, cognitive restructuring, graduated exposure to anxiety-provoking situations and intolerance of uncertainty, problem-solving, and behavioral exercises. Sessions were delivered weekly in a standardized, manualized format by a trained therapist, without spiritual or religious content.
Other: Waiting Group
There is no intervention for this group
Participants assigned to the waitlist control group did not receive any active intervention during the study period and were offered the intervention after completion of post-test assessments.
Experimental: Religiously Integrated Cognitive Behavioral Group Therapy
Participants in this group received 10 sessions of online religiously integrated cognitive behavioral group therapy
This intervention consists of a structured, group-based, online cognitive behavioral therapy program integrated with participants' spiritual/religious values. The program includes psychoeducation about anxiety, cognitive restructuring, exposure to uncertainty, problem-solving, and behavioral exercises, combined with spiritually framed coping strategies such as meaning-making, patience, gratitude, trust, and values-based reflection. Sessions were delivered weekly in a standardized manualized format by a trained therapist. The intervention aimed to reduce anxiety symptoms and enhance psychological well-being.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: Baseline (pre-test), immediately post-intervention (post-test), and 2-month follow-up.
The Anxiety Thoughts Inventory (AnTI) is a self-report measure assessing the frequency of anxiety-related thoughts. The total score is calculated by summing item responses, with higher scores indicating greater levels of maladaptive anxious thinking. Lower scores reflect fewer anxiety-related cognitions and improvement over time. Change in scores from baseline to post-intervention and follow-up represents a reduction in anxiety-related thought patterns.
Baseline (pre-test), immediately post-intervention (post-test), and 2-month follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being
Time Frame: Baseline (pre-test), immediately post-intervention (post-test), and 2-month follow-up.
The PERMA Well-Being Scale is a self-report measure assessing overall psychological well-being across five domains: Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment. Total scores are derived by averaging item responses, with higher scores indicating higher levels of psychological well-being. An increase in total score reflects improvement in overall well-being.
Baseline (pre-test), immediately post-intervention (post-test), and 2-month follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ekinci, PhD Candidate, Ibn Haldun University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2024

Primary Completion (Actual)

September 9, 2024

Study Completion (Actual)

September 21, 2024

Study Registration Dates

First Submitted

December 31, 2025

First Submitted That Met QC Criteria

December 31, 2025

First Posted (Estimated)

January 12, 2026

Study Record Updates

Last Update Posted (Estimated)

January 12, 2026

Last Update Submitted That Met QC Criteria

December 31, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

Individual participant data (IPD) will be made available beginning 6 months after publication of the primary study results and will remain available for a period of 5 years.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Well Being

Clinical Trials on Traditional Cognitive Behavioral Group Therapy

Subscribe